[Possibilities of the clinical use of a purified fraction of Agkistrodon rhodostoma venom in anticoagulant therapy].
作者信息
Isidori A, Fischetti I, Pallotta S, Piro C
出版信息
Minerva Med. 1974 Dec 12;65(89):4656-70.
PMID:4437809
Abstract
摘要
相似文献
1
[Possibilities of the clinical use of a purified fraction of Agkistrodon rhodostoma venom in anticoagulant therapy].
Minerva Med. 1974 Dec 12;65(89):4656-70.
2
[Anticoagulant activity of Agkistrodon rhodostoma venom].[红口蝮蛇毒的抗凝活性]
Clin Ter. 1974 Dec 15;71(5):409-25.
3
[Anticoagulants in prophylactics and therapy].[预防性和治疗性抗凝剂]
Kardiol Pol. 1977;20(4):273-80.
4
[Therapy with snake venom proteases].
Bull Schweiz Akad Med Wiss. 1973 Nov;29(4):244-52.
5
[Current concepts on the anticoagulant therapy].[抗凝治疗的当前概念]
Presse Med (1893). 1970 Jan 17;78(3):127-8.
6
[Conservative therapy of chronic arterial occlusive diseases using subcutaneous administration of the rheologically effective snake venom Arwin].采用皮下注射具有流变学活性的蛇毒Arwin对慢性动脉闭塞性疾病进行保守治疗
Verh Dtsch Ges Kreislaufforsch. 1974;40:243-5.
7
Anticoagulant therapy with a purified fraction of Malayan pit viper venom.使用马来亚蝮蛇毒的纯化组分进行抗凝治疗。
Lancet. 1968 Mar 9;1(7541):493-9. doi: 10.1016/s0140-6736(68)91466-9.
8
9
[Indications for and hazards of anticoagulant therapy].
Schweiz Med Wochenschr. 1970 Apr 18;100(16):686-91.
10
[Evaluation of anticoagulant therapy in the Neurological Department of the Warsaw Medical Academy].[华沙医学院神经科抗凝治疗的评估]
Pol Tyg Lek. 1965 Jun 28;20(26):962-5.
Zotero 插件